{"id":38491,"date":"2026-07-17T01:30:00","date_gmt":"2026-07-16T23:30:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=0757d4d89ee8280046ea7b1bf86cbc31"},"modified":"2026-07-17T01:30:00","modified_gmt":"2026-07-16T23:30:00","slug":"ubs-announces-redemption-of-seven-etns-2","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=38491","title":{"rendered":"UBS Announces Redemption of Seven ETNs"},"content":{"rendered":"

NEW YORK--(BUSINESS WIRE)--UBS AG announced today that it will redeem all of the outstanding securities in each of the seven series of UBS-issued exchange traded notes set forth in the following table (collectively, the \u201cETNs\u201d), which are currently listed on NYSE Arca. UBS AG expects to deliver redemption notices with respect to each of the ETNs to holders of the applicable ETNs with Call Settlement Dates as set forth in the table below.<\/p><\/a><\/a>

\nTable-1<\/b><\/p>\n\n\n\n\n\n\n\n\n

\nETN Ticker<\/b><\/p><\/td>

\nETN Name and Prospectus Supplement [1]<\/sup><\/b><\/p><\/td>

\nCUSIP<\/b><\/p><\/td>

\nCall Settlement\nDate<\/b><\/p><\/td><\/tr>\n

\nIWDL<\/p><\/td>

\nETRACS 2x Leveraged US Value Factor TR ETN<\/a> due February 9, 2051[2]<\/sup><\/p><\/td>

\n90278V107<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nIWFL<\/p><\/td>

\nETRACS 2x Leveraged US Growth Factor TR ETN<\/a> due February 9, 2051[2]<\/sup><\/p><\/td>

\n90278V305<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nIWML<\/p><\/td>

\nETRACS 2x Leveraged US Size Factor TR ETN<\/a> due February 9, 2051[2]<\/sup><\/p><\/td>

\n90278V404<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nMTUL<\/p><\/td>

\nETRACS 2x Leveraged MSCI US Momentum Factor TR ETN<\/a> due February 9, 2051[2]<\/sup><\/p><\/td>

\n90278V602<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nQULL<\/p><\/td>

\nETRACS 2x Leveraged MSCI US Quality Factor TR ETN<\/a> due February 9, 2051[2]<\/sup><\/p><\/td>

\n90278V503<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nSCDL<\/p><\/td>

\nETRACS 2x Leveraged US Dividend Factor TR ETN<\/a> due February 9, 2051[2]<\/sup><\/p><\/td>

\n90278V206<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nUSML<\/p><\/td>

\nETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN<\/a> due February 9, 2051[2]<\/sup><\/p><\/td>

\n90278V701<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n<\/table>

\n[1]<\/sup><\/b> The table above provides a hyperlink to the relevant prospectus supplement for each of the ETNs, which are identified by their names. Each of the above ETNs are part of the UBS AG\u2019s Medium Term Notes, Series B, on which UBS AG is sole obligor. Capitalized terms used but not defined in this press release shall have the meanings ascribed to such terms in the relevant prospectus supplement (including, as applicable, any product supplement and pricing supplement (each such supplement, a \u201cprospectus supplement\u201d)) for the ETNs.<\/p>

\n[2]<\/sup><\/b> The prospectus addendum with a link to the updated base prospectus can be accessed here<\/a>.<\/p>

\nThe Call Settlement Amount payable on the Call Settlement Date will be calculated as specified in the relevant prospectus supplement. UBS will pay the applicable Call Settlement Amount to investors holding such ETNs on the applicable Call Settlement Date.<\/p>

\nWe expect that the last day of trading for the ETNs will be August 18, 2026.<\/p>

\nAdditional details regarding the redemption dates and valuation dates are included in Table-2 below.<\/p>

\nTable-2<\/b><\/p>\n\n\n\n\n\n\n\n\n

\nETN Ticker<\/b><\/p><\/td>

\nCall Measurement\nPeriod<\/b><\/p><\/td>

\nCall Measurement\nPeriod Start Date &\nCall Measurement\nPeriod End Date<\/b><\/p><\/td>

\nCall Valuation Date<\/b><\/p><\/td>

\nCall Settlement\nDate<\/b><\/p><\/td><\/tr>\n

\nIWDL<\/p><\/td>

\n1 Index Business Day<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nIWFL<\/p><\/td>

\n1 Index Business Day<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nIWML<\/p><\/td>

\n1 Index Business Day<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nMTUL<\/p><\/td>

\n1 Index Business Day<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nQULL<\/p><\/td>

\n1 Index Business Day<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nSCDL<\/p><\/td>

\n1 Index Business Day<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n

\nUSML<\/p><\/td>

\n1 Index Business Day<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/14\/2026<\/p><\/td>

\n08\/19\/2026<\/p><\/td><\/tr>\n<\/table>

\nAs disclosed in more detail in the applicable prospectus supplement(s) for the ETNs, the market value of the ETNs may be influenced by, among other things, supply and demand for the ETNs. It is possible that the discontinuance of further issuances of the ETNs by UBS AG may influence the market value of the ETNs. The suspension of new issuances of the ETNs could affect the liquidity of the market for the ETNs, potentially leading to insufficient supply and causing the ETNs to trade at a premium above their closing or intraday indicative value. Any such premium may subsequently decrease at any time and for any reason without warning, resulting in financial loss to sellers who paid this premium when they acquired their ETNs. In addition, on the applicable Call Settlement Date, holders will receive the Call Settlement Amount, as described in each applicable prospectus supplement but will not receive any premium thereto. Accordingly, investors who purchase the ETNs at any time prior to the Call Settlement Date for an amount that is greater than the Call Settlement Amount (including paying any premium to the indicative value of the ETNs), will suffer a loss on their investment if they hold their ETNs until the Call Settlement Date.<\/p>

\nIf investors elect to redeem any such ETNs, any redemption will be at the redemption value set forth in the applicable prospectus supplement(s) and will not include any premium above that value. Investors should always consult their financial advisors and compare the intraday indicative value of the ETNs with the ETNs\u2019 then-prevailing market price before purchasing or selling any such ETNs, especially notes with premium characteristics. The applicable prospectus supplement(s) for the ETNs can be accessed by clicking on the name of the ETN identified in the table above as well as on the SEC's website at sec.gov.<\/p>

\nThis announcement does not affect the terms of the outstanding ETNs, including the right of holders to require UBS AG to redeem their ETNs on the terms and at the redemption price set forth in the applicable prospectus supplement(s). This news release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these ETNs in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.<\/p>

\nCautionary Statement Regarding Forward-Looking Statements<\/b><\/p>

\nThis press release contains statements that constitute \u201cforward-looking statements\u201d that are subject to risks and uncertainties, and actual results may differ materially. These statements could contain words such as \u201cpossible,\u201d \u201cintend,\u201d \u201cwill,\u201d \u201cmay,\u201d \u201cintends,\u201d \u201cwould,\u201d \u201cif,\u201d \u201cexpect,\u201d \u201cpotentially\u201d or other similar expressions. Forward-looking statements, including those relating to UBS AG\u2019s plans for the ETNs, are based on management\u2019s current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. While these forward-looking statements represent UBS\u2019s judgments, expectations and objectives concerning the matters described, a number of risks, uncertainties and other important factors, including whether UBS AG will actually complete the redemption of the ETNs, could cause actual developments and results to differ materially from UBS\u2019s expectations. For a discussion of the risks and uncertainties that may affect the ETNs please refer to the \"Risk Factors\" in the applicable prospectus supplement(s) relating to the ETNs referenced in Table-1. UBS is not under any obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements, whether as a result of new information, future events, or otherwise.<\/p>

\nAbout ETRACS ETNs<\/b><\/p>

\nETRACS ETNs are senior unsecured notes issued by UBS AG, are traded on NYSE Arca or NASDAQ, and can be bought and sold through a broker or financial advisor. An investment in ETRACS ETNs is subject to a number of risks, including the risk of loss of some or all of the investor\u2019s principal, and is subject to the creditworthiness of UBS AG. Investors are not guaranteed any coupon or distribution amount under the <\/b>ETRACS<\/b><\/a> ETNs. Prior to making an investment in the ETRACS ETNs, investors should take into account whether or not the market price is tracking the intraday indicative value of the ETRACS ETNs. We urge you to read the more detailed explanation of risks described under \u201cRisk Factors\u201d in the applicable prospectus supplement for each ETRACS ETN.<\/b><\/p>

\nUBS AG has filed a registration statement (including a prospectus and supplements thereto) with the Securities and Exchange Commission, or SEC, for the offerings of securities to which this communication relates. Before you invest, you should read the relevant prospectus, along with the applicable prospectus supplement(s) and\/or pricing supplement(s) to understand fully the terms of the ETNs and other considerations that are important in making a decision about investing in the ETNs. The applicable offering document for each ETN may be obtained by clicking on the name of each ETN identified above. You may also get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov<\/a>. The securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.<\/p>

\nAbout UBS<\/b><\/p>

\nUBS is a leading and truly global wealth manager and the leading universal bank in Switzerland. It also provides diversified asset management solutions and focused investment banking capabilities. UBS manages 6.9 trillion dollars of invested assets as per the first quarter 2026. UBS helps clients achieve their financial goals through personalized advice, solutions and products. Headquartered in Zurich, Switzerland, the firm is operating in more than 50 markets around the globe. UBS Group shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).<\/p>

\nIn the US, securities underwriting, trading and brokerage activities and M&A advisor activities are provided by UBS Securities LLC, a registered broker\/dealer that is a wholly owned subsidiary of UBS AG, a member of the New York Stock Exchange and other principal exchanges, and a member of SIPC (http:\/\/www.sipc.org\/<\/a>). UBS Financial Services Inc. is a registered broker\/dealer and affiliate of UBS Securities LLC.<\/p>

\nThis material is issued by UBS AG and\/or any of its subsidiaries and\/or any of its affiliates (\"UBS\"). This document was produced by and the opinions expressed are those of UBS as of the date of writing and are subject to change. It has been prepared solely for information purposes and for the use of the recipient. It does not constitute an offer or an invitation by or on behalf of UBS to any person to buy or sell any security. The information and analysis contained in this publication have been compiled or arrived at from sources believed to be reliable but UBS does not make any representation as to their accuracy or completeness and does not accept liability for any loss arising from the use hereof. Products and services mentioned in this material may not be available for residents of certain jurisdictions. Past performance is not necessarily indicative of future results. Please consult the restrictions relating to the product or service in question for further information.<\/p>

\nThe IWFL, IWML and IWDL ETNs (the \u201cRussell ETNs\u201d) have been developed solely by UBS. The Russell ETNs are not in any way connected to or sponsored, endorsed, sold or promoted by the London Stock Exchange Group plc and its group undertakings (collectively, the \u201cLSE Group\u201d). FTSE Russell is a trading name of certain of the LSE Group companies. All rights in the FTSE Russell Indices (the \u201cRussell Indices\u201d) vest in the relevant LSE Group company which owns the Russell Indices. \u201cRussell\u00ae\u201d and \u201cFTSE Russell\u00ae\u201d are a trademarks of the relevant LSE Group company and are used by any other LSE Group company under license. The Russell Indices are calculated by or on behalf of FTSE International Limited or its affiliate, agent or partner. The LSE Group does not accept any liability whatsoever to any person arising out of (a) the use of, reliance on or any error in the Russell Indices or (b) investment in or operation of the Russell ETNs. The LSE Group makes no claim, prediction, warranty or representation either as to the results to be obtained from the Russell ETNs or the suitability of the Russell Indices for the purpose to which it is being put by UBS.<\/p>

\nThe ETNs referred to herein are not sponsored, endorsed, issued, sold or promoted by MSCI, and MSCI bears no liability with respect to any such ETNs or any index on which such ETNs are based. The respective prospectus supplement contains a more detailed description of the limited relationship MSCI has with UBS.<\/p>

\nThe Dow Jones US Dividend 100 TR USD Index (\u201cDow Jones Index\u201d) is a product of S&P Dow Jones Indices LLC and has been licensed for use by UBS AG. Copyright \u00a9 2026 S&P Dow Jones Indices LLC (\u201cS&P DJI\u201d), a division of S&P Global. All rights reserved. S&P\u00ae is a registered trademark of Standard & Poor\u2019s Financial Services LLC (\u201cS&P\u201d) and Dow Jones\u00ae is a registered trademark of Dow Jones Trademark Holdings LLC (\u201cDow Jones\u201d). ETNs based on the Dow Jones Index are not sponsored, endorsed, marketed or sold by S&P DJI, S&P, Dow Jones, their affiliates or third party licensors and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of the Dow Jones Index.<\/p>

\nUBS specifically prohibits the redistribution or reproduction of this communication in whole or in part without the prior written permission of UBS and UBS accepts no liability whatsoever for the actions of third parties in this respect.<\/p>

\n\u00a9 UBS 2026. The key symbol, UBS and ETRACS are among the registered and unregistered trademarks of UBS. Other marks may be trademarks of their respective owners. All rights reserved.<\/p>\n\n\n
_______________________________________<\/td>\n<\/tr>\n

\n1<\/sup><\/p><\/td>

\n

\nIndividual investors should instruct their broker\/advisor\/custodian to call us or should call together with their broker\/advisor\/custodian.<\/p><\/td><\/tr>\n<\/table>

\n\u00a0<\/p> Contacts<\/b>

\nMedia<\/b>Alison Keunen\n+1 212-713-2296\nalison.keunen@ubs.com<\/a><\/p>

\nInstitutional Investor1<\/sup><\/b>+1-877-387-2275<\/p>","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–UBS AG announced today that it will redeem all of the outstanding securities in each of the seven series of UBS-issued exchange traded notes set forth in the following table (collectively, the \u201cETNs\u201d), which are currently lis…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-38491","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38491"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38491\/revisions"}],"predecessor-version":[{"id":38493,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38491\/revisions\/38493"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}